Claret Medical Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 120

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $270M

Claret Medical General Information

Description

Developer of a cerebral protection system designed to reduce the risk of stroke during transcatheter aortic valve replacement (TAVR). The company's cerebral protection system offers endovascular technology and cerebral vascular-protection systems for transcatheter aortic valve implantation and surgical aortic valve replacement, enabling medical institutes to capture and remove debris dislodged during TAVR procedures, preventing it from traveling to the brain where it may cause injury.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 1745 Copperhill Parkway
  • Suite 1
  • Santa Rosa, CA 95403
  • United States
+1 (707)
Primary Industry
Surgical Devices
Acquirer
Boston Scientific
Vertical(s)
Corporate Office
  • 1745 Copperhill Parkway
  • Suite 1
  • Santa Rosa, CA 95403
  • United States
+1 (707)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Claret Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 02-Aug-2018 $270M Completed Generating Revenue
6. Later Stage VC (Series C) 01-Oct-2017 Completed Generating Revenue
5. Early Stage VC (Series B2) 03-Jun-2016 Completed Generating Revenue
4. Debt - General 03-Mar-2016 Completed Generating Revenue
3. Early Stage VC (Series B) 01-Apr-2015 Completed Generating Revenue
2. Early Stage VC (Series A) 24-Aug-2011 $4.33M $4.33M Completed Startup
1. Early Stage VC 01-Jan-2009 Completed Startup
To view Claret Medical’s complete valuation and funding history, request access »

Claret Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B-2
Series B-1 20,271,214 $0.000010 8% $0.39 $0.39 1x $0.33 13.46%
Series A 4,779,181 $0.000010 8% $1 $1 1x $0.33 8.24%
To view Claret Medical’s complete cap table history, request access »

Claret Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a cerebral protection system designed to reduce the risk of stroke during transcatheter aortic valve replac
Surgical Devices
Santa Rosa, CA
120 As of 2018

Amiens, France
 

Santa Cruz, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Claret Medical Competitors (16)

One of Claret Medical’s 16 competitors is Open Stent Solution, a Venture Capital-Backed company based in Amiens, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Open Stent Solution Venture Capital-Backed Amiens, France
Emboline Venture Capital-Backed Santa Cruz, CA
Revamp Medical Venture Capital-Backed Netania, Israel
Emblok Private Equity-Backed Tampa, FL
Artio Venture Capital-Backed Prairie Village, KS
You’re viewing 5 of 16 competitors. Get the full list »

Claret Medical Patents

Claret Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11382441-B2 Portable filter Active 26-Apr-2019
US-20200337486-A1 Portable filter Active 26-Apr-2019
US-11351023-B2 Systems and methods for protecting the cerebral vasculature Active 21-Aug-2018
US-11439491-B2 Systems and methods for protecting the cerebral vasculature Active 26-Apr-2018
US-12409022-B2 Systems and methods for protecting the cerebral vasculature Active 26-Apr-2018 A61F2/013
To view Claret Medical’s complete patent history, request access »

Claret Medical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Claret Medical Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Easton Capital Investment Group Venture Capital Minority
Gore Range Capital Venture Capital Minority
HealthCor Partners Management Growth/Expansion Minority
Incept Venture Capital Minority
Lightstone Ventures Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Claret Medical FAQs

  • When was Claret Medical founded?

    Claret Medical was founded in 2009.

  • Where is Claret Medical headquartered?

    Claret Medical is headquartered in Santa Rosa, CA.

  • What is the size of Claret Medical?

    Claret Medical has 120 total employees.

  • What industry is Claret Medical in?

    Claret Medical’s primary industry is Surgical Devices.

  • Is Claret Medical a private or public company?

    Claret Medical is a Private company.

  • What is the current valuation of Claret Medical?

    The current valuation of Claret Medical is .

  • What is Claret Medical’s current revenue?

    The current revenue for Claret Medical is .

  • How much funding has Claret Medical raised over time?

    Claret Medical has raised $67M.

  • Who are Claret Medical’s investors?

    Easton Capital Investment Group, Gore Range Capital, HealthCor Partners Management, Incept, and Lightstone Ventures are 5 of 7 investors who have invested in Claret Medical.

  • Who are Claret Medical’s competitors?

    Open Stent Solution, Emboline, Revamp Medical, Emblok, and Artio are some of the 16 competitors of Claret Medical.

  • When was Claret Medical acquired?

    Claret Medical was acquired on 02-Aug-2018.

  • Who acquired Claret Medical?

    Claret Medical was acquired by Boston Scientific.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process